معرفی
Laura Fanning is a Senior Research Fellow at the Centre for Health Economics (Monash Business School) and the Transfusion Research Unit (Monash University). She holds qualifications including a BPharm(Hons), MPH, and PhD. Her research focuses on evaluating the effectiveness, safety, and cost-effectiveness of pharmaceuticals and blood products, particularly in the context of healthcare treatments and submissions to regulatory bodies like the Pharmaceutical Benefits Advisory Committee (PBAC). Methodological expertise includes economic evaluation alongside clinical trials, causal inference using healthcare data, and discrete choice experiments.
Education:
- Bachelor of Pharmacy with Honours
- Master of Public Health
- Doctor of Philosophy
Research interests span health economic evaluation, pharmacoepidemiology, and health technology assessment. Recent work emphasizes optimizing immunoglobulin therapy in blood cancers and evaluating prophylactic antibiotic use.
Awards:
- 2021 Ronald D. Mann Best Paper Award for contributions to pharmacoepidemiology research.
Key projects include the OPTIMAL and RATIONALISE trials addressing immunoglobulin management in Australia, and the ACTMed trial investigating pharmacist-led medication reconciliation.
Labs/Teams: Collaborations include the Transfusion Research Unit and interdisciplinary teams focused on myeloma treatment modeling and cost-effectiveness analyses.
